Home
About
Overview
Sharing Data
ORCID
Help
History (47)
Leveraging health system telehealth and informatics infrastructure to create a continuum of services for COVID-19 screening, testing, and treatment.
ETS transcription factors and regulation of immunity.
Coping motives for drinking affect stress reactivity but not alcohol consumption in a clinical laboratory setting.
Gammaretrovirus
Linaclotide: a novel agent for chronic constipation and irritable bowel syndrome.
See All 47 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Linaclotide: a novel agent for chronic constipation and irritable bowel syndrome.
Linaclotide: a novel agent for chronic constipation and irritable bowel syndrome. Am J Health Syst Pharm. 2014 Jul 01; 71(13):1081-91.
View in:
PubMed
subject areas
Animals
Chronic Disease
Clinical Trials as Topic
Constipation
Gastrointestinal Diseases
Humans
Irritable Bowel Syndrome
Peptides
authors with profiles
Bryan L Love